News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
376,087 Results
Type
Article (18360)
Company Profile (312)
Press Release (357415)
Section
Business (111446)
Career Advice (435)
Deals (21531)
Drug Delivery (51)
Drug Development (61591)
Employer Resources (52)
FDA (9286)
Job Trends (7618)
News (202048)
Policy (16923)
Tag
Academia (1249)
Alliances (28373)
Alzheimer's disease (998)
Approvals (9250)
Artificial intelligence (98)
Bankruptcy (191)
Best Places to Work (6738)
Biotechnology (255)
Breast cancer (142)
Cancer (1092)
Cardiovascular disease (89)
Career advice (380)
CAR-T (84)
Cell therapy (249)
Clinical research (49545)
Collaboration (372)
Compensation (148)
COVID-19 (1384)
C-suite (91)
Cystic fibrosis (76)
Data (1198)
Diabetes (121)
Diagnostics (2956)
Earnings (46528)
Events (60704)
Executive appointments (292)
FDA (9800)
Funding (348)
Gene therapy (177)
GLP-1 (379)
Government (1931)
Healthcare (9778)
Infectious disease (1441)
Inflammatory bowel disease (105)
IPO (11354)
Job creations (1231)
Job search strategy (338)
Layoffs (210)
Legal (2922)
Lung cancer (152)
Lymphoma (76)
Manufacturing (124)
Medical device (6182)
Medtech (6184)
Mergers & acquisitions (10365)
Metabolic disorders (339)
Neuroscience (1267)
NextGen Class of 2024 (2943)
Non-profit (1385)
Northern California (1343)
Obesity (192)
Opinion (133)
Parkinson's disease (81)
Patents (88)
People (31446)
Phase I (16515)
Phase II (22501)
Phase III (15515)
Pipeline (458)
Postmarket research (1271)
Preclinical (6756)
Radiopharmaceuticals (221)
Rare diseases (231)
Real estate (2115)
Regulatory (13042)
Research institute (1206)
Southern California (1180)
Startups (2239)
United States (11232)
Vaccines (249)
Weight loss (122)
Date
Last 7 days (471)
Last 30 days (1856)
Last 365 days (26990)
2024 (26853)
2023 (29939)
2022 (36110)
2021 (38021)
2020 (34002)
2019 (24007)
2018 (17755)
2017 (19632)
2016 (17026)
2015 (20753)
2014 (15145)
2013 (11201)
2012 (11470)
2011 (12023)
2010 (11391)
Location
Africa (290)
Arizona (77)
Asia (26024)
Australia (5596)
California (3026)
Canada (1180)
China (244)
Colorado (120)
Connecticut (143)
Europe (50384)
Florida (383)
Georgia (98)
Illinois (202)
Indiana (120)
Japan (71)
Maryland (416)
Massachusetts (2398)
Michigan (74)
Minnesota (145)
New Jersey (885)
New York (828)
North Carolina (559)
Northern California (1343)
Ohio (95)
Pennsylvania (649)
South America (449)
Southern California (1180)
Texas (397)
Washington State (343)
376,087 Results for "bicycle therapeutics limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Bicycle Therapeutics to Participate in Upcoming June 2024 Investor Conferences
Bicycle Therapeutics plc, a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will participate in the following investor conferences in June.
June 3, 2024
·
2 min read
Press Releases
Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
November 12, 2024
·
1 min read
Press Releases
Bicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology Experts
December 10, 2024
·
6 min read
Business
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported recent business progress and financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
9 min read
Press Releases
Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification
December 13, 2024
·
13 min read
Deals
Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
Bicycle Therapeutics plc today announced that the company has entered into a securities purchase agreement with certain existing and new accredited investors to issue and sell an aggregate of 25,933,706 American Depositary Shares.
May 23, 2024
·
6 min read
Press Releases
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
October 31, 2024
·
13 min read
Press Releases
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 2, 2024
December 3, 2024
·
2 min read
Press Releases
Bicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program Update
November 25, 2024
·
3 min read
Press Releases
Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress
October 16, 2024
·
5 min read
1 of 37,609
Next
